Reinventing Clinical Trial Data with Digital Health Technologies

Incorporating Clinical Insights and Data Analytics



TI is to achieve digital transformation through new information and value creation
by combining clinical trial experiences and insight with IT technology for pharmaceutical bio customers
and through genuinely differentiated digital data integration platforms that are based on international regulations.


Our Team



CEO  Dr. Kyung Won Kim

CEO, Trial Informatics (2021.01 – now)

Professor, Radiology Department, Asan Medical Center, Korea (2013.09 – now)

Co-founder, Asan Image Metrics, Korea (2017.04 – now)

Cancer Imaging Fellow, Dana-Farber Cancer Institute (2012-2013)  

PhD, Seoul National University College of Medicine (2012)

MD, Seoul National University College of Medicine (2002, Summa Cum Laude) 

Certificate of Clinical Trials Professionals, KONECT (2019-now)

RECIST Qualification, Training Certificate, EORTC/ESOI (2019)

SCI(E) publications (n=209), Patents (n=13) Section Editor, Cancer Imaging
Fellow, International Cancer Imaging Society
Peer Reviewer at Radiology, JAMA oncology, KJR, etc

MD, PhD  

Bhumsuk Keam

Oncology &

Clinical Trial Expert

PhD, M.B.A

Jeongjin Lee

AI medical imaging

Expert

CTO

Youngbin Shin

Clinical Trial Digital
Data Platform Specialist

Data Scientist

YoungChul Cho

Clinical Trial Imaging
Data Scientist

R&D Director

Mi-hyun Kim

Clinical Trial Imaging
Data Scientist

Data Scientist

Yousun Ko

Artificial Intelligence
Medical Imaging

IT Manager

Ji Woo Lee

Clinical Trial Digital
Data Platform Specialist


Our Team










|  CEO  |  Dr. Kyung Won Kim


- CEO, Trial Informatics (2021.01 – now)

- Professor, Radiology Department, Asan Medical Center, Korea (2013.09 – now)

- Co-founder, Asan Image Metrics, Korea (2017.04 – now)

- Cancer Imaging Fellow, Dana-Farber Cancer Institute (2012-2013)  

- PhD, Seoul National University College of Medicine (2012)

- MD, Seoul National University College of Medicine (2002, Summa Cum Laude)

- Certificate of Clinical Trials Professionals, KONECT (2019-now)

- RECIST Qualification, Training Certificate, EORTC/ESOI (2019)

- SCI(E) publications (n=209), Patents (n=13)

- Section Editor, Cancer Imaging

- Fellow, International Cancer Imaging Society

- Peer Reviewer at Radiology, JAMA oncology, KJR, etc


Jeongjin Lee

PhD, M.B.A

AI medical imaging

Expert

Youngbin Shin

CTO

Clinical Trial Digital
Data Platform Specialist

Young Chul Cho

CDO

Clinical Trial Imaging
Data Scientist

SoYoung Chun

CBO

Pharmaceutical Bio & 

CRO Specialist

Yousun Ko

Data Sceintist

Artificial Intelligence
Medical Imaging

Mi-hyun Kim

R&D Director

Clinical Trial Imaging
Data Scientist

Henry Kye

Head

Digital Product Unit

Data Scientist

Our History

2021
  • Jan.  Established from Asan Medical Center in Seoul (AMC)
  • Feb.   Received seed funding from SNU's technology holding company (SNU: Seoul National University)
  • Mar.   Acquired corporate affiliation lab Signed the contract for a right to use iAID technology
  • May.   Received seed funding from <C&R> Selected as an Initial start-up
  • Jun.   Selected as a growth technology development start-up: Didmdol first step
  • Jul.   Launched OncoTrial Board
  • Aug.   Acquired officially registered as a venture business
  • Oct.   Online Exhibitor at <2021 KoNECT-MOHW-MFDS International Conference>
  • Nov.   Selected as Asan Medical Center in Seoul business of Bio Core Facility Center
2022
  • Feb.   Collaborated with KCSG (Korean Cancer Study Group) 
  • Apr.  Selected in <TIPS>& as linked business, an investment driven tech incubator program 
  • Jul.   Acquired GCP Quality Audit Good Software
  • Sep.  Acquired ISO/IEC 27001:2013 Certificate 
  • Oct.  Exhibitor at <2022 KoNECT-MOHW-MFDS International Conference>
  • Nov.   Exhibitor at <RSNA 2022>
  • Dec.   Exhibitor at <International R&D Industry –Con 2022>

Qualification


    Our History
























2021

Jan.

Feb. 

Mar. 

May. 

Jun. 

Jul. 

Aug. 

Oct. 

Nov. 

Dec.

Established from Asan Medical Center in Seoul (AMC)

Received seed funding from SNU's technology holding company (SNU: Seoul National University)

Acquired corporate affiliation lab Signed the contract for a right to use iAID technology

Received seed funding from <C&R> Selected as an Initial start-up

Selected as a growth technology development start-up: Didmdol first step

Launched OncoTrial Board

Acquired officially registered as a venture business

Online Exhibitor at <2021 KoNECT-MOHW-MFDS International Conference>

Selected as Asan Medical Center in Seoul business of Bio Core Facility Center

Acquired ISO900 Vendor Qualification from C&R


2022

Feb. 

Apr.

Jul. 

Sep.

Oct.

Nov. 

Dec. 

Collaborated with KCSG (Korean Cancer Study Group) 

Selected in <TIPS>& as linked business, an investment driven tech incubator program 

Acquired GCP Quality Audit Good Software

Acquired ISO/IEC 27001:2013 Certificate 

Exhibitor at <2022 KoNECT-MOHW-MFDS International Conference>

Exhibitor at <RSNA 2022>

Exhibitor at <International R&D Industry –Con 2022>



Qualification

        

        


Address  88, Olympic-ro 43-gil, Songpa-gu, Seoul, Rep. of Korea

E-mail  cs@trialinformatics.com

Tel  1800-7260

Copyright ⓒ Trial Informatics All rights reserved.

                                                                                                                              개인정보 처리 방침                                                            

Address          6, Wiryeseong-daero, Songpa-gu, Seoul, Republic of Korea                                                                                             

E-mail            cs@trialinformatics.com

Tel                  1800-7260

Copyright ⓒ Trial Informatics All rights reserved.